<code id='5FB26992E2'></code><style id='5FB26992E2'></style>
    • <acronym id='5FB26992E2'></acronym>
      <center id='5FB26992E2'><center id='5FB26992E2'><tfoot id='5FB26992E2'></tfoot></center><abbr id='5FB26992E2'><dir id='5FB26992E2'><tfoot id='5FB26992E2'></tfoot><noframes id='5FB26992E2'>

    • <optgroup id='5FB26992E2'><strike id='5FB26992E2'><sup id='5FB26992E2'></sup></strike><code id='5FB26992E2'></code></optgroup>
        1. <b id='5FB26992E2'><label id='5FB26992E2'><select id='5FB26992E2'><dt id='5FB26992E2'><span id='5FB26992E2'></span></dt></select></label></b><u id='5FB26992E2'></u>
          <i id='5FB26992E2'><strike id='5FB26992E2'><tt id='5FB26992E2'><pre id='5FB26992E2'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:2828
          Vertex Pharmaceuticals - sunset
          Bill Sikes/AP

          Vertex Pharmaceuticals has spent decades trying to develop molecules that reduce pain safely and potently, searching for success in a field its own executives have dubbed a graveyard for drug discovery. Detailed data published Wednesday lent support to that quest, with a pair of company-sponsored clinical trials showing an experimental non-opioid therapy reduced pain after surgery.

          The drug, VX-548, blocks signals from pain-sensitive neurons before those electrical messages reach the brain. And in a pair of randomized trials, patients given a high dose of the oral medication after bunion surgery or abdominoplasty (a tummy tuck) reported less pain than those given a placebo. Those taking lower doses of the treatment showed no improvement compared to the placebo group, however.

          advertisement

          While the pain reduction measured by these Phase 2 trials was statistically significant, it’s unclear how meaningful the drug’s benefits were to patients, with a commentary accompanying the study describing the treatment effect as “small.” But the study authors noted that participants on a high dose of VX-548 were less likely to prematurely stop their treatment because it wasn’t working than those on placebo or participants given a combination of two common painkillers, acetaminophen and hydrocodone.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more
          Weight loss drug costs may need more research, senator suggests
          Weight loss drug costs may need more research, senator suggests

          Sen.BillCassidy(R-La.)KevinDietsch/GettyImagesWASHINGTON—WithNovoNordisk’sWegovyandOzempichittingblo

          read more
          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more

          Gain of function research would be limited under House proposal

          Rep.ThomasMassie(R-Ky.)KevinDietsch/GettyImagesWASHINGTON—HouselawmakerslateTuesdayvotedtoattachaU.S